Sofiva Genomics Co.,Ltd. (TPEX:6615)
Taiwan · Delayed Price · Currency is TWD 33.00
+0.10 (0.30%)
Jun 3, 2026, 1:30 PM CST
Sofiva Genomics Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 8.39 | -9.36 | 18.43 | 11.53 | 42.78 | 56.98 |
Depreciation & Amortization | 41.49 | 41.61 | 41.62 | 41.34 | 42.79 | 41.95 |
Loss (Gain) From Sale of Assets | 0.02 | 0.02 | - | - | -0.02 | - |
Loss (Gain) on Equity Investments | -33.9 | -23.3 | -25.35 | -23.67 | -41.9 | -31.05 |
Stock-Based Compensation | - | -0.01 | -0.73 | 1.07 | 2.68 | 2.87 |
Provision & Write-off of Bad Debts | 0.02 | 0.01 | - | 0 | -0.49 | -0.14 |
Other Operating Activities | 4.01 | 1.39 | 8.46 | -3.92 | -2.99 | 1.58 |
Change in Accounts Receivable | -0.92 | 2.94 | 5.6 | -2.23 | 0.94 | -12.39 |
Change in Inventory | 12.64 | 11.55 | -4.61 | 15.29 | -15.52 | 8.55 |
Change in Accounts Payable | -5 | 0.17 | -9.25 | -18.89 | -3.64 | 7.72 |
Change in Unearned Revenue | -1.02 | -0.59 | 1 | -1.34 | -0.58 | -0.56 |
Change in Other Net Operating Assets | 2.28 | -9.07 | -0.5 | 4.5 | -6.92 | 4.56 |
Operating Cash Flow | 28.02 | 15.36 | 34.69 | 23.7 | 17.14 | 80.07 |
Operating Cash Flow Growth | -18.98% | -55.73% | 46.38% | 38.30% | -78.60% | 31.65% |
Capital Expenditures | -1.13 | -1.16 | -16.92 | -21.01 | -33.53 | -8.16 |
Sale of Property, Plant & Equipment | 0.04 | 0.04 | - | - | 0.1 | - |
Sale (Purchase) of Intangibles | -3.98 | -7 | -7.2 | -3.55 | -2.17 | -4.49 |
Investment in Securities | - | - | 9.13 | 7.93 | -20.95 | - |
Other Investing Activities | -7.61 | -6.33 | 4.33 | 6.65 | 3.07 | 2.62 |
Investing Cash Flow | -12.68 | -14.44 | -10.66 | -9.99 | -53.48 | -10.03 |
Long-Term Debt Repaid | - | -15.25 | -15.81 | -14.74 | -15.75 | -15.54 |
Total Debt Repaid | -14.63 | -15.25 | -15.81 | -14.74 | -15.75 | -15.54 |
Net Debt Issued (Repaid) | -14.63 | -15.25 | -15.81 | -14.74 | -15.75 | -15.54 |
Issuance of Common Stock | - | - | 12.07 | - | - | 1.12 |
Common Dividends Paid | -6.48 | -6.48 | -4.27 | -21.36 | -42.73 | -29.77 |
Other Financing Activities | -0.55 | -0.55 | -0.55 | -0.57 | -0.18 | -0 |
Financing Cash Flow | -21.66 | -22.28 | -8.57 | -36.67 | -58.65 | -44.19 |
Foreign Exchange Rate Adjustments | 0.01 | -0.11 | -0.19 | -0.05 | -0.18 | 0.29 |
Net Cash Flow | -6.29 | -21.47 | 15.27 | -23.01 | -95.18 | 26.14 |
Free Cash Flow | 26.9 | 14.2 | 17.77 | 2.69 | -16.4 | 71.91 |
Free Cash Flow Growth | 50.52% | -20.11% | 560.18% | - | - | 58.55% |
Free Cash Flow Margin | 7.03% | 3.68% | 3.92% | 0.58% | -3.31% | 14.14% |
Free Cash Flow Per Share | 1.25 | 0.66 | 0.82 | 0.13 | -0.77 | 3.38 |
Cash Interest Paid | 0.8 | 0.8 | 1.07 | 1.24 | 1.44 | 1.69 |
Cash Income Tax Paid | - | -0.32 | -3.23 | 1.34 | 7.61 | 5.19 |
Levered Free Cash Flow | 25.45 | 16.9 | 10.12 | 2.66 | -20.41 | 63.61 |
Unlevered Free Cash Flow | 25.93 | 17.43 | 10.81 | 3.47 | -19.48 | 64.7 |
Change in Working Capital | 7.99 | 5 | -7.75 | -2.66 | -25.72 | 7.88 |